B
one marrow (BM)-derived MSCs can regenerate diseased myocardium and accelerate bone and soft tissue repair (1-3). MSCs are rare in the BM but can be isolated by selecting the adherent, spindle-shaped cells that expand from mononuclear cells in humans, rodents and pigs (4) (5) (6) . Engrafted MSCs dramatically reduce the extent of necrotic myocardium and promote the regeneration of new, contractile myocardium (1, 7, 8) . As with other BM-derived cells, the molecular pathways that modulate MSCmediated tissue repair are not completely understood.
To better understand the role of stem cells in regenerative biology, we studied the ''superhealer'' MRL/MpJ mouse, generated by interbreeding 4 different strains (9) . This strain was found to be capable of completely closing 2 mm surgical ear holes within 30 days whereas control (Bl/6) mice leave residual, open holes (10) . Upon right ventricular cryoinjury, this ''superhealer'' demonstrated regeneration of the wound with scarless myocardium, whereas the control mice demonstrated acellular scars (11) . Using a BM sexmismatched transplant model, the authors showed that MRL hearts had 3-fold greater BM-derived cells in the myocardium than uninjured animals or injured WT mice (11) . More recently, the group showed that myocardial regeneration in this model could be recapitulated in WT (C57BL/6) mice after BM engraftment with hematopoietic cells derived from MRL/MpJ fetal liver (12) . This led us to hypothesize that BM-derived cells from the MRL strain may exhibit an enhanced regenerative phenotype. Our findings show enhanced efficacy of BM-derived MRL-MSCs and demonstrate that this phenotype is due to the activity of the Wnt signaling modulator, secreted frizzled-related protein 2 (sFRP2).
Wnt/␤-catenin signaling is necessary for the commitment/ differentiation of mesenchymal cells to osteocytes, chondrocytes and adipocytes (13) (14) (15) (16) . Consistent with this, the Wnt inhibitor, Dkk1, promotes human MSC self-renewal (17) . sFRP family of proteins bind directly to Wnts to prevent receptor binding and activation of Wnt signaling (18) . Our study shows that sFRP2 directly modulates MSC proliferation and engraftment and that increased sFRP2 expression in MSCs is associated with enhanced therapeutic efficacy of MSC therapy in wound granulation tissue formation and in repair of infarcted myocardium.
Results

Isolation and Characterization of 2 Populations of MSCs.
Murine MSCs were isolated from both MRL/MpJ (MRL, n ϭ 2 independent lines) and Bl/6 (WT) strain (an additional Bl/6 MSC isolate was purchased from Tulane Center for Gene Therapy). The MSCs were characterized by immunofluorescent staining and confirmed to be CD45 Ϫ , CD11b
Ϫ (data not shown). These MSCs were positive for the cell surface antigens Sca1 ϩ and CD44 ϩ as analyzed by flow cytometry [supporting information (SI) Fig. S1a ]. To confirm MSC phenotype (19, 20) , each line was shown to be capable of differentiation along 3 principal lineages: osteoblast, adipocyte, and chondrocyte ( Fig. S1 b and c) . Studies were performed with at least 2 different MSC lines of each phenotype and the data combined.
MRL-MSCs Engrafted Extensively and Induced Vigorous, Well-Vascu-
larized Granulation Tissue. To compare the effect of the different MSCs in promoting both the quantity and quality of granulation tissue deposition, we used the PVA sponge model of repair stimulation. This model is widely used to study granulation tissue deposition resembling healing by secondary intention (21, 22) . MSC engraftment (persistence in tissue), vascularity, and organization of the resultant granulation tissue were compared among sponges implanted into the same animal and across multiple animals. When implanted into mice genetically deficient for ␤-glucuronidase (␤-gluc), both WT-and MRL-loaded sponges gave rise to abundant granulation tissue compared with sponges loaded with vehicle (PBS) (Fig. 1 A-C) . This enabled us to distinguish ␤-gluc-positive MSC-derived tissue (i.e., assess engraftment) from ␤-gluc-negative host tissue. Sponges injected with MRL-MSCs had significantly greater amount of granulation tissue over a given cross-sectional area than those loaded with WT-MSCs ( Fig. 1 A-C) . Granulation tissues observed in sponges treated with MRL-MSCs ( Fig. 1 C and  F) and WT-MSCs ( Fig. 1 B and E) appeared highly organized with abundant collagen deposition. By contrast, sponges treated with PBS (Fig. 1D ) demonstrated loose, disorganized tissue architecture with markedly reduced collagen deposition. The majority of the granulation tissue in MSC-loaded sponges (Fig. S1d) showed substantial engraftment with implanted MSCs as evidenced by the extensive, red (␤-gluc-positive) histochemical staining whereas the PBS-loaded sponges (negative control) contained only ␤-glucnegative host cells. Biochemical measurement for ␤-gluc enzyme activity (a quantitative measure of MSC engraftment) showed greater than 3-fold increased engraftment of MRL-MSCs compared with WT-MSCs ( Fig. 2A) . Furthermore, the granulation tissue derived from MRL-MSCs was comparatively more vascularized than that from WT-MSCs as determined by greater density of PECAM-1 immunopositive vascular structures (Figs. 1 H and I and 2B). The observed increased engraftment with MRL-MSCs is consistent (in part) with greater than 2-fold increased in vitro proliferation of MRL-MSCs over WT-MSCs (Fig. 2C) . However, the number of cells (affected by proliferation rate) does not correlate directly with engraftment, suggesting that these are distinct mechanisms (23) .
MRL-MSCs Displayed a Down-Regulation of Wnt Target Genes and
Increased Expression of sFRPs. To determine the molecular basis for the enhanced repair properties of MRL-MSCs, we compared their gene expression to WT-MSCs. Several inhibitors of the ␤-catenin/ Wnt (canonical) signaling pathway belonging to the sFRP family were significantly enriched in MRL-MSCs (Fig. 3A ). An evaluation of target genes that are known to be transcriptionally up-regulated by the canonical Wnt pathway (and hence should be decreased in MRL-MSCs) uncovered 3 genes, Cyclin D1 (24), Sox2 (25) and Axin2 (26) , that had Ͼ4-fold reduced expression in MRL-MSCs ( Fig. 3A and Table S1 ). Interestingly, the microarray data showed increased Wnt4 transcripts in MRL-MSCs. Wnt4 is involved in regulating mesenchymal to epithelial transformation in the kidney and whose activity is thought to be regulated by sFRP2; in other reports Wnt4 induces sFRP2 expression (27) . Quantitative realtime RT-PCR confirmed the gene expression differences for a subset of these genes (Table S1 and Table S2 ). sFRP2 and sFRP4 transcripts were up-regulated in MRL-MSCs by Ͼ250-and 30-fold, respectively. The aforementioned canonical target genes were significantly downregulated in MRL-MSCs between 5-and 12-fold, consistent with the genomic profile (Table S1 ).
This gene expression signature would predict a reduction in canonical Wnt signaling in MRL-MSCs. An optimized version of the TOPFlash reporter was used to compare constitutive ␤-cateninmediated transcriptional activation in MRL-and WT-MSCs (28) (Fig. 2D) . Consistent with our prediction, MRL-MSCs exhibited a significant reduction in TOPFlash/FOPFlash ratio under basal conditions. We next assessed if murine and human MSC proliferation was modulated by Wnt signaling (Fig. 3B) . Wnt pathway activation through either addition of LiCl or recombinant murine Wnt3a decreased proliferation for both murine (WT and MRL) and human MSCs; the small decrease of human MSC proliferation with Wnt3a treatment was not statistically significant, possibly reflecting species-specific differences in Wnt/Frizzled receptors. Dkk1, surprisingly, did not affect murine MSCs but showed a statistically significant increase with human MSC proliferation in vitro, consistent with previous studies (17, 29) . Although sFRP4 increased WT-MSC proliferation, only sFRP2 mediated a consistent and notable increase in proliferation in both murine and human MSC lines. To underscore the significance of the Wnt pathway in engraftment of MRL-MSCs in vivo, we injected LiCl every other day directly into WT-or MRL-MSC preloaded sponges. As anticipated, LiCl-mediated activation of canonical Wnt signaling significantly reduced MRL-MSC engraftment to levels comparable with WT-MSCs (Fig. S2 ).
MSCs Differentially Expressed Wnt Constituents. To investigate the contribution of secreted Wnt pathway members on the regulation of ␤-catenin in MSCs in vivo, we generated stably-transduced WT-MSC lines overexpressing Wnt3a, Dkk1 or sFRP2. Coexpression of GFP with each cDNA enabled FACS enrichment of vector-transduced MSCs (Ͼ90%; data not shown; see Table S3 ). Control transducts were generated that expressed GFP alone (GFP-MSC). Fold increase of sFRP2 protein expression in transduced WT cells (sFRP2-MSCs) assessed by immunoblot was comparable to the fold increase observed between GFP-MSCs and MRL-MSCs (Fig. 4A ). Wnt3a expression was verified by immunofluorescent staining of sorted (GFP-positive) cells as it was difficult to obtain sufficient numbers of cells for an immunoblot (Fig. S3a) ; overexpression of Wnt3a in MSCs (Wnt3a-MSCs) abrogated their proliferation in culture (Fig. 4B ). MSC transducts expressing Dkk1 (Dkk1-MSCs), sFRP2 or GFP retained the capacity for trilineage differentiation ( Fig. S3 b and c) and express CD44 and Sca1 by FACS (data not shown). Regulation of canonical Wnt signaling activity of conditioned media from each MSC transduct line was assessed in HEK 293 cells stably transfected with TOPFlash Wnt reporter system. Recombinant protein was used as a positive control. As expected, conditioned media from Wnt3a-MSC resulted in increased luciferase activity over conditioned media from vector-transfected MSCs (GFP-MSC), whereas conditioned media from Dkk1-or sFRP2-MSCs resulted in comparatively reduced ␤-catenin-mediated transcriptional activity (Fig. S3d) . Wnt signaling in sFRP2-MSCs was decreased compared with GFP-MSCs as assessed by luciferase activity after transfection with TOP/ FOPFlash reporter constructs (Fig. S3e) .
sFRP2 Enhanced MSC-Mediated Wound Repair. As discussed, Wnt3a expression abolished MSC proliferation and these cells died after 4-6 weeks in culture. By contrast, overexpression of sFRP2 resulted in Ͼ3-fold increase in proliferation as compared with GFP-MSC (Fig. 4B) . Overexpression of Dkk1 did not alter the proliferation rate over GFP-MSCs (Fig. S4b) . These effects are consistent with our observation using recombinant proteins (Fig. 3B) . Moreover, further testing of Dkk1-MSC transducts failed to show changes in murine MSC engraftment or MSC-derived sponge granulation tissue (Fig. S4c) over GFP-MSCs, suggesting that murine MSCs, unlike human MSCs, failed to respond to Dkk1-mediated Wnt inhibition.
To assess the role of the Wnt inhibitor sFRP2 in promoting both the quantity and quality of MSC-generated granulation tissue, we loaded PVA sponges with sFRP2-or GFP-MSCs before implantation into ␤-gluc-deficient mice. ␤-gluc enzyme activity in granulation tissue was significantly increased (Ͼ3-fold) in sFRP2-MSCloaded sponges compared with GFP-MSC-loaded controls (Fig.  4C) . Furthermore, examination of vascular density using PE-CAM-1 immunostaining showed that granulation tissue generated from sFRP2-MSCs was more densely vascularized than GFP-MSCs (Fig. 4D) . To examine if sFRP2-MSCs directly contributed to the microvasculature of granulation tissue, we performed colocalization by confocal microscopy using anti-GFP (to identify MSCs) and anti-PECAM-1. MSC-derived vascular structures were evident within the MSC-derived granulation tissue (Fig. S5a) suggesting that MSCs underwent transdifferentiaion into the endothelial lineage to contribute to repair tissue vasculature.
Proliferation and Enhanced Engraftment of MRL-MSCs Are Mediated
by sFRP2. We sought to determine is sFRP2 inhibition could abrogate the MRL-MSC phenotype. Knockdown of sFRP2 mRNA transcripts with 3 independent shRNAs were assessed by real-time RT-PCR (Table S4) . MRL-kd-MSCs (derived using shRNA clone 75B) were expanded and further tested by immunoblot and showed a Ϸ70% reduction in sFRP2 protein as compared with MRL-MSCs stably transduced with control shRNA (Fig. 4A) . Specific sFRP2 knockdown also decreased proliferation by 2-fold over control shRNA-MSCs (Fig. 4B) . Furthermore, MRL-kd-MSCs showed Ͼ5-fold decrease in MSC engraftment in experimental granulation tissue (Fig. 4C) . Importantly, the experimental granulation tissue generated by MRL-kd-sFRP2 were also 3-fold less densely vascularized, as assessed by PECAM-1 staining, when compared with control shRNA MRL-MSCs-loaded sponges (Fig. 4D) . We then assessed whether sFRP2 overexpression could improve MSC-mediated myocardial regeneration by injecting sFRP2-MSCs, In vitro proliferation of murine and human MSCs relative to basal levels (e.g., media alone) in the presence of LiCl (10 mM) or various recombinant Wnt pathway factors: 50 ng/ml Wnt3a, 100 ng/ml sFRP2, 100 ng/ml sFRP3, 2 g/ml sFRP4, or 100 ng/ml Dkk1. The data shown are the fold change relative to media alone within each given cell type. Data are from at least 3 experiments performed in triplicate. Unpaired
Student's t test with Bonferroni's correction was used. * , P Ͻ 0.05.
GFP-MSCs, MRL-MSCs, or vehicle PBS into the periinfarct area of the left ventricle after coronary artery ligation. Ventricular remodeling and cardiac function were analyzed by echocardiography at 7 and 30 days post MI (Table 1) . Left ventricle (LV) internal dimension diastolic (LVIDD) and LV internal dimension systolic (LVIDS) reflect remodeling of the infarcted ventricle. At 30 days post MI, both dimensional parameters were smaller in the MRL-MSC and sFRP2-MSC recipients, suggesting a role for sFRP2 in chamber remodeling. The percentage difference in LVIDS between day 7 and day 30 was significantly reduced in animals receiving sFRP2-MSCs (Fig. 5A ). When compared with the GFP-MSC, recipients of both the MRL-MSC and sFRP2-MSC showed improved ventricular remodeling. To determine whether sFRP2 improved cardiac function, the percentage differences in ejection fraction (EF) and fractional shortening (FS) (Fig. 5B ) between 7 and 30 days after treatment were analyzed ( Table 1 ). The MRL recipients showed an increase in both ⌬EF (2.17%) and ⌬FS (3.18%) when compared with WT-MSC (Ϫ7.28% and Ϫ10.28%, respectively) and PBS-injected (Ϫ9.89% and Ϫ13.17%, respectively) controls. In contrast, sFRP2-MSC cohorts exhibited significant functional improvement 30 days post infarct (⌬EF 6.24% and ⌬FS 13.82%). These results together indicate sFRP2 overexpression has a significant positive effect on cardiac function. Mean percentage of LV area infarcted in PBS-treated control animals was 26 Ϯ 10% ( Fig. 5C and Fig. S5b) . Injection of GFP-MSCs had a modest protective effect, limiting the extent of the infarction to 14% of LV (p ϭ NS) (Fig. 5C ). In contrast, injection of MRL-MSCs significantly limited infarct size to 6.0% of the LV (P Ͻ 0.05 vs. PBS). Notably, injection of sFRP2-MSCs limited infarct size even more dramatically to 3.4% (P Ͻ 0.05 vs. PBS and the GFP-MSC group). Compared with the PBS group, we observed a relative reduction in infarct size of 12% in the GFP-MSC group and 23% in the sFRP2-MSC group.
Myocardial engraftment of MSCs was assessed by counting GFP-positive cells. Whereas significant engraftment was evident grossly within granulation tissue of sponge implants (Fig. 1G and Fig. S5c ), the numbers of MSCs within the myocardium 30 days after injection were comparatively fewer (Fig. S5c) . However, the sFRP2-MSCs resulted in a significant increase in the number of engrafted MSCs compared with controls (Fig. 5D) . We examined the myocardial scar region for colocalization of GFP-MSCs with endothelial (anti-PECAM-1) or cardiomyocyte (anti-␣-actinin) specific marker and did not observe any (data not shown). Vascular density of the scarred region was assessed by immunohistochemistry for PECAM-1 and showed a statistically significant increase with sFRP2-MSCs compared with GFP-MSCs (Fig. 5E and Fig.  S5d ).
Discussion
Although MSCs are a promising source of cell therapy for heart and wound regeneration, little is known about the molecular pathways that modulate MSC-mediated regeneration and repair (3, 23) . Furthermore, the extent to which repair and regeneration mediated by MSCs relies on their engraftment and direct contribution versus serving as effectors to alter the stem cell microenvironment is not understood (3). The distinct soft tissue repair models used in this PBS n ϭ 7, GFP-MSC n ϭ 6, MRL-MSC n ϭ 5, sFRP2-MSC n ϭ 7. study provided different in vivo contexts to study MSC-driven therapy. The sponge soft tissue repair model also permitted clear demarcation and evaluation of angiogenesis, organization, and contribution of MSC-derived granulation tissue. The isolation and characterization of 2 strain specific populations of MSCs with differing in vivo regenerative properties led us to identify sFRP2 as a key molecule that mediates self-propagation of both human and mouse MSCs in vitro and whose overexpression enhanced MSCmediated angiogenesis and therapeutic potency.
A role for Wnt signaling in modulating MSC biology was suggested by molecular profiling of the MSC populations isolated from the regenerative MRL/MpJ mice, as compared with the MSCs isolated from WT (Bl/6) strain. Together, our data suggest that Wnt signaling inhibition correlated with the superior properties exhibited by MRL-MSCs; these included enhanced proliferation and the ability to mediate more abundant, better organized and vascularized granulation tissue in implanted PVA sponges. Consistent with our findings, several lines of evidence from published reports (13-16) support a role for Wnt inhibition in regulating mesenchymal stem cell self-renewal and expansion. Importantly, Wnt/␤-catenin activation has been shown to be necessary for the commitment/differentiation of mesenchymal cells to osteocytes, chondrocytes, myoblasts, and adipocytes (13) (14) (15) (16) . Additionally, Dkk1, an inhibitor of the canonical Wnt pathway, increased human MSC proliferation and promoted entry into the cell cycle in vitro (17) . Consistent with these studies, our findings support a role for canonical Wnt activation in MSC lineage commitment and, conversely, Wnt inhibition in self-renewal.
Recently, Liu et al. (30) reported that accelerated aging and associated depletion and dysfunction in stem cells in various tissues and organs is associated with increased Wnt activity. Expression of klotho, a secreted protein that binds and sequesters Wnt and leads to suppression of Wnt activity, and its absence in mice leads to early onset age-related changes (30) . Another study found that activation of Wnt signaling promoted tissue specific stem cell aging and increased tissue fibrosis (31) . Both studies broadly support our hypothesis and link Wnt inhibition to stem cell maintenance and function (30, 31) .
We identified an effect of sFRP2, an inhibitor of Wnt signaling, on MSC self-propagation by comparing MSCs from mouse strains with markedly different healing properties. Whereas canonical Wnt activation, either through addition of exogenous activators or by induced overexpression of Wnt3a, dramatically inhibited baseline MSC proliferation, addition of sFRP2 resulted in significantly increased proliferation of both mouse and human MSCs. This increase was much greater than that seen with other sFRPs tested and recombinant Dkk1, which caused a statistically significant increase in hMSC proliferation. Dkk1 inhibits Wnt signaling by binding to LRP5 and LRP6 and blocking their interaction with Wnt and Frizzled (32) . Kremen 1 and 2 are transmembrane Dkk1 receptors that synergize with Dkk1 to inhibit Wnt signaling (32) . Kremen transcripts were undetected in murine MSCs through microarray analysis (data not shown). This observation may explain the lack of response of murine, but not human, MSCs to Dkk1. Interestingly, despite the very high level of endogenous sFRP2 in MRL-MSCs, addition of increasing amounts of recombinant sFRP2 continued to increase proliferation, suggesting significant residual Wnt activity and/or non-canonical roles of sFRP2. Moreover, specific knockdown of sFRP2 in MRL-MSCs resulted in abrogation of the comparatively enhanced wound tissue reconstitution phenotype observed in MRL-MSCs.
MSCs genetically modified to overexpress sFRP2 or Dkk1 were used to investigate the effect of these factors in MSC-mediated tissue repair. Importantly, increased constitutive expression of either Wnt pathway molecule did not abolish expression of mouse MSC surface markers, such as CD44 or Sca1, or the capacity for multilineage differentiation, albeit our experiments did not address whether these factors affected differentiation kinetics. sFRP2-MSCs replicated the MRL-MSC phenotype of enhanced engraftment in situ, increased angiogenesis, and in the setting of acute myocardial injury, resulted in significantly reduced infarct size. Consistent with the histological data, there was enhanced residual myocardial function and attenuation of adverse cardiac remodeling 30 days post MI. Although the numbers of sFRP2-MSCs remaining 30 days post infarction (engraftment) were greater than GFPMSCs, the overall number of implanted MSCs remaining in the myocardium was considerably lower than those comprising the granulation tissue formed in the sponge model (Fig. S5) . This finding would suggest that type of injury and the stem cell microenvironment may influence the underlying mechanisms of repair, i.e., direct contribution vs. paracrine effects. The data also suggest that the injury environment may dramatically affect implanted stem cell survival and persistence in vivo. The molecular signals that impact the degree of MSC engraftment are not known.
sFRP2 was first isolated from a BM-derived stromal cell line and was proposed to serve as an inhibitor of Wnt signaling by binding and sequestering the Drosophila Wnt homologue, Wingless (33) . Subsequent studies have shown inhibition of Wnt signaling by direct binding to and sequestering of Wnt3a (34) . sFRP2 has been shown to protect against UV-or TNF-induced apoptosis in a canine cancer cell line (18) . Recently sFRP2 was found to be a key factor secreted by genetically engineered MSCs overexpressing Akt (35) . This last study showed that much of the MSC-mediated improvement in myocardial function resulting from Akt-MSC therapy could be attributed to a downstream increase in sFRP2. Moreover, sFRP2 was shown to directly prevent cardiomyocyte death, and thereby, serve as a stem cell-derived paracrine factor to influence cardiomyoctye survival and repair (35) . The enhanced myocardial repair observed in our study can be attributed, at least in part, to this mechanism. Our study also demonstrated that sFRP2 caused a robust increase in MSC therapy-induced angiogenesis. sFRP1 and 4 overexpression in endothelium have recently been shown to increase neovascularization in hindlimb ischemia by regulation of Wnt and Rac1 signaling (36) . We do not know, however, whether sFRP2 works in a similar manner via direct paracrine effects on endothelial cells, indirectly via up-regulation of other angiogenic factors, or via MSC propagation. Notably, a variety of key proangiogenic genes are up-regulated in sFRP2-MSCs compared with GFP-MSCs as determined by gene expression profiling (Table S5) . Finally, our findings also demonstrate that, in addition to potential paracrine function on target tissues, sFRP2 serves an autocrine and/or cell-intrinsic role in MSCs to mediate self-propagation and engraftment. MSCs appear to be multipotential effector cells whose own preservation and growth in vivo, such as those mediated by sFRP2, may lead to enhanced regenerative efficacy. The mechanism by which sFRP2 modulates MSC proliferation and tissue engraftment is not known. sFRP2, but not other sFRPs tested, uniquely enhanced robust proliferation. Understanding the molecular regulation of MSCs by sFRP2 would have important implications for improving cell-based therapies using MSCs for wound and myocardial repair. 
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